- The trend backdrop is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
ORNBV
HEL
Week ended 07 Aug 2026
Weekly Investor Report
Orion Oyj · Healthcare · Drug Manufacturers - General
Latest close
81.50 EUR
0.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 15.2% above the Trend Line and sits at 95.2% of its 52-week range. The latest completed week returned 0.5%, after a 17.0% four-week move. The latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high.
Setup score
79
out of 100
Latest Close
81.50 EUR
7 Aug 2026
1W Return
0.5%
latest completed week
4W Return
17.0%
short-term follow-through
12W Return
19.8%
quarterly tape
Trend Breadth
71.2%
37 of 52 weeks active
Volume Ratio
1.2x
vs 13-week average
- 4 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.5%
Latest completed week; four-week move 17.0%.
Indicator stack
84/95
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 60.13%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
56/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 15.2% above the Trend Line and sits at 95.2% of its 52-week range. The latest completed week returned 0.5%, after a 17.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7212-week average 0.62
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.72Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers
No recent accumulation markers. 4 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 17.0% over four weeks, 19.8% over 12 weeks, and 27.8% over one year. The current trend has remained active for 25 consecutive weeks.
Performance by holding period
Active trend streak25 weeks
Active weeks in one year37
Trend breadth71.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.25Latest activity-pressure read.
Pressure change282.2%Four-week change in activity pressure.
Leadership11.42Latest relative-leadership reading.
RS change358.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment56/100
Weighted news tone is neutral across 13 relevant articles.
2 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-1.6%Distance below the 52-week high.
13-week volatility3.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+11.1%Week of 17 Jul.
Worst week-11.2%Week of 24 Apr.
Latest week+0.5%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains10
Flat weeks0
Modest losses10
Sharp losses2
Recent vol3.8%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.7% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFI Healthcare
4-week rank3 / 16
Group average1.5%
Trend breadth18.8%
Trend18.8%active weekly trend signals
MD68.8%positive activity pressure
RS18.8%positive relative leadership
Four-week leaders
IndustryFI Drug Manufacturers - General
4-week rank2 / 2
Group average17.2%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape77/100
Trend, activity pressure, participation, and risk combine to a 77/100 tape read.
Indicator analysis50/100Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 4/12.
Activity pressure 0.72; 4 reversal markers Next-Week ExpectancyPositive 60.13%Next-week expectancy is positive with a 60.13% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment56/100Weighted news tone is neutral across 13 relevant articles.
Is Orion Oyj (HLSE:ORNBV) Undervalued Following Strong Earnings And Higher 2026 Guidance? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 81.50 EUR | 0.5% | 70.77 EUR | 51.27 EUR | 1.25 | 11.42 | 609.3K | On |
| 31 Jul 2026 | 81.10 EUR | 3.4% | 70.22 EUR | 50.96 EUR | 0.81 | 11.22 | 804.9K | On |
| 24 Jul 2026 | 78.45 EUR | 1.4% | 69.60 EUR | 50.64 EUR | 0.37 | 7.71 | 1.2M | On |
| 17 Jul 2026 | 77.40 EUR | 11.1% | 69.07 EUR | 50.35 EUR | -0.14 | 6.48 | 1.1M | On |
| 10 Jul 2026 | 69.65 EUR | -3.3% | 68.54 EUR | 50.06 EUR | -0.69 | -4.42 | 675.7K | On |
| 3 Jul 2026 | 72.00 EUR | 2.9% | 68.19 EUR | 49.83 EUR | -0.79 | -3.00 | 104.5K | On |
| 26 Jun 2026 | 70.00 EUR | 4.8% | 67.79 EUR | 49.58 EUR | -0.81 | -3.98 | 126.6K | On |
| 19 Jun 2026 | 66.80 EUR | -2.3% | 67.49 EUR | 49.36 EUR | -0.69 | -9.97 | 301.2K | On |
| 12 Jun 2026 | 68.35 EUR | -3.2% | 67.23 EUR | 49.15 EUR | -0.44 | -9.70 | 160.5K | On |
| 5 Jun 2026 | 70.60 EUR | -1.1% | 66.93 EUR | 48.95 EUR | -0.46 | -8.97 | 37.2K | On |
| 29 May 2026 | 71.35 EUR | 0.1% | 66.44 EUR | 48.73 EUR | -0.51 | -8.24 | 453.7K | On |
| 22 May 2026 | 71.25 EUR | 4.7% | 66.06 EUR | 48.51 EUR | -0.55 | -8.87 | 664.0K | On |
| 15 May 2026 | 68.05 EUR | -0.7% | 65.93 EUR | 48.30 EUR | -0.55 | -10.10 | 573.9K | On |
| 8 May 2026 | 68.55 EUR | -0.2% | 65.87 EUR | 48.10 EUR | -0.12 | -9.10 | 707.1K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.